Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

2NZX

Crystal Structure of alpha1,3-Fucosyltransferase with GDP

Summary for 2NZX
Entry DOI10.2210/pdb2nzx/pdb
Related2NZW 2NZY
DescriptorAlpha1,3-fucosyltransferase, GUANOSINE-5'-DIPHOSPHATE, SULFATE ION, ... (4 entities in total)
Functional Keywordsalpha1, 3-fucosyltransferase, fucosyltransferase, fuct, gt 10, transferase
Biological sourceHelicobacter pylori
Cellular locationMembrane ; Peripheral membrane protein : O30511
Total number of polymer chains3
Total formula weight130795.74
Authors
Sun, H.Y.,Ko, T.P. (deposition date: 2006-11-27, release date: 2007-01-23, Last modification date: 2023-12-27)
Primary citationSun, H.Y.,Lin, S.W.,Ko, T.P.,Pan, J.F.,Liu, C.L.,Lin, C.N.,Wang, A.H.,Lin, C.H.
Structure and mechanism of Helicobacter pylori fucosyltransferase. A basis for lipopolysaccharide variation and inhibitor design.
J. Biol. Chem., 282:9973-9982, 2007
Cited by
PubMed Abstract: Helicobacter pylori alpha1,3-fucosyltransferase (FucT) is involved in catalysis to produce the Lewis x trisaccharide, the major component of the bacteria's lipopolysaccharides, which has been suggested to mimic the surface sugars in gastric epithelium to escape host immune surveillance. We report here three x-ray crystal structures of FucT, including the FucT.GDP-fucose and FucT.GDP complexes. The protein structure is typical of the glycosyltransferase-B family despite little sequence homology. We identified a number of catalytically important residues, including Glu-95, which serves as the general base, and Glu-249, which stabilizes the developing oxonium ion during catalysis. The residues Arg-195, Tyr-246, Glu-249, and Lys-250 serve to interact with the donor substrate, GDP-fucose. Variations in the protein and ligand conformations, as well as a possible FucT dimer, were also observed. We propose a catalytic mechanism and a model of polysaccharide binding not only to explain the observed variations in H. pylori lipopolysaccharides, but also to facilitate the development of potent inhibitors.
PubMed: 17251184
DOI: 10.1074/jbc.M610285200
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.9 Å)
Structure validation

227111

PDB entries from 2024-11-06

PDB statisticsPDBj update infoContact PDBjnumon